ArticlemAbs2026

Discovery and optimization of marstacimab, a human monoclonal antibody targeting tissue factor pathway inhibitor for the treatment of hemophilia A and B.

Macy Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.